Shareholders’ Nomination Board
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces that the following members have been appointed by a meeting of the Company's five largest shareholders to Faron Pharmaceuticals Oy's Shareholders' Nomination Board:
- Timo Syrjälä, representing himself (Chair)
- Erkka Kohonen, representing Varma Mutual Pension Insurance Company, and
- Joonas Haakana, representing UMO Capital
Faron's Shareholders' Nomination Board consists of three members, which represent the Company's shareholders. The Chair of Faron's Board of Directors, Mr. Tuomo Pätsi, will serve as an expert in the Nomination Board without being a member.
The Shareholders' Nomination Board prepares and presents proposals to the Annual General Meeting on the number, composition and remuneration of the members of the Board as well as the Chair of the Board of Directors.
About bexmarilimab
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.